U.S. market Closed. Opens in 6 hours 5 minutes

ETON | Eton Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue31.64M21.25M21.83M39.00K959.00KN/A
Cost of Revenue10.58M6.93M2.62M286.00K453.00KN/A
Gross Profit21.06M14.32M19.21M-247.00K506.00KN/A
Operating Expenses22.25M22.58M20.70M26.86M19.11M10.32M
Selling, General & Admin18.93M18.58M14.47M12.76M7.55M4.69M
Research & Development3.32M4.00M6.24M14.10M11.55M5.63M
Other Operating ExpensesN/AN/AN/AN/AN/AN/A
Operating Income-1.19M-8.26M-1.50M-27.11M-18.60M-10.32M
Other Expenses / Income503.00K-761.00K-460.00K-859.00K281.00K-2.58M
Before Tax Income-689.00K-9.02M-1.96M-27.97M-18.32M-12.74M
Income Tax Expenses247.00K761.00K1.01M859.00K-281.00K-2.58M
Net Income-936.00K-9.78M-2.96M-28.83M-18.04M-12.74M
Interest Expenses503.00K-761.00K1.01M-859.00KN/AN/A
Basic Shares Outstanding25.65M25.15M25.21M21.01M17.76M6.42M
Diluted Shares Outstanding25.65M25.15M25.21M21.01M17.76M6.42M
EBITDA-291.00K-6.49M-1.03M-26.46M-18.15M-7.67M
EBITDA Margin-0.92%-30.52%-4.73%-67,846.15%-1,893.01%0.00%
EBIT-186.00K-9.78M-949.00K-28.83M-18.32M-15.32M
EBIT Margin-0.59%-46.03%-4.35%-73,920.51%-1,910.32%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙